We then mined data from TCGA and found that high METTL14 exhibited more favorable OS in many human cancer types with wild‐type p53 regardless of spectrum of p53 mutations, whereas high METTL14 has no significant positive association with OS, or even has poorer OS in some types of tumors with medium to high frequency of p53 mutations. Here, METTL14 is linked to cancer.